WorkBoat Header Background Image

WorkBoat+ Membership – Free to Join

Now Available: The U.S. Dredge Report 2025 — download today for expert dredging market insights and data → Click Here

Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

217.97 +1.97 (+0.91%)
Streaming Delayed Price Updated: 2:03 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom
From Insulet Corporation
Via Business Wire
News headline image
Expert Ratings for Insulet ↗
 
Via Benzinga
News headline image
Medtronic's EOflow Acquisition Will Not Impact Insulet's Omnipod' Insulin Pump In Near or Medium Term: Analyst ↗
 
Via Benzinga
News headline image
Insulet Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
AMD Stock, AI Play And New S&P 500 Member Lead 5 Stocks Near Buy Points ↗
AMD and a new S&P 500 member lead this weekend's watch list. 
Via Investor's Business Daily
News headline image
Recap: Insulet Q1 Earnings ↗
 
Via Benzinga
News headline image
4 Analysts Have This to Say About Insulet ↗
 
Via Benzinga
News headline image
Analyst Expectations for Insulet's Future ↗
 
Via Benzinga
News headline image
Preview: Insulet's Earnings ↗
 
Via Benzinga
News headline image
Insulet Reports Better-Than-Expected Q1 Earnings As Omnipod 5 Launch Gains Momentum, Lifts Guidance ↗
  
Via Benzinga
News headline image
Insulet Announces New Organizational Structure to Drive Further Growth
From Insulet Corporation
Via Business Wire
News headline image
Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)
From Insulet Corporation
Via Business Wire
News headline image
Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment
From Insulet Corporation
Via Business Wire
News headline image
Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes
From Insulet Corporation
Via Business Wire
News headline image
5 S&P 500 Stocks Showing Strength As Recession Fears Rise ↗
Medical stocks are holding up amid economic and market uncertainty. 
Via Investor's Business Daily
News headline image
Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023
From Insulet Corporation
Via Business Wire
News headline image
CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)
From Insulet Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
From Insulet Corporation
Via Business Wire
News headline image
3 Growth Stocks That Have Delivered 10X Returns Over the Past Decade ↗
Are these stocks still good buys today? 
Via The Motley Fool
News headline image
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
From Insulet Corporation
Via Business Wire
News headline image
Earnings Scheduled For February 23, 2023 ↗
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
News headline image
Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies
From Insulet Corporation
Via Business Wire
News headline image
The 7 Best Tech Stocks to Buy for February 2023 ↗
Some of the best tech stocks are looking increasingly attractive as the worst fears fail to materialize. Here are seven to consider. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023 ↗
 
Via Benzinga
News headline image
Insulet Has Potential To Gain More Than Analysts Are Forecasting
Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range. 
Via MarketBeat
News headline image
Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
From Insulet Corporation
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Dow Jones Giant UnitedHealth Among 5 Resilient Stocks In Sickly Market Rally ↗
UnitedHealth is among medical stocks holding key support. 
Via Investor's Business Daily
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Privacy Policy DSAR Requests Terms of Use Locations Events, Products & Services
© 2026 Diversified Communications. All rights reserved.